126 related articles for article (PubMed ID: 10705239)
1. Expression of tumor suppressor gene p16(INK4) products in primary gastric cancer.
Tsujie M; Yamamoto H; Tomita N; Sugita Y; Ohue M; Sakita I; Tamaki Y; Sekimoto M; Doki Y; Inoue M; Matsuura N; Monden T; Shiozaki H; Monden M
Oncology; 2000 Feb; 58(2):126-36. PubMed ID: 10705239
[TBL] [Abstract][Full Text] [Related]
2. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of cell cycle regulators in gastric carcinoma].
Wu JF; Shao JC; Wang DB; Qin R; Zhang H
Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle dysregulation influences survival in high risk breast cancer patients.
Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
[TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation of p16, survivin, and retinoblastoma in gastric cancer.
Guo L; Huang C; Ji QJ
Bratisl Lek Listy; 2017; 118(3):164-168. PubMed ID: 28319413
[TBL] [Abstract][Full Text] [Related]
6. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
Ghazizadeh M; Jin E; Shimizu H; Fujiwara M; Arai S; Ohaki Y; Takemura T; Kawanami O
Respiration; 2005; 72(1):68-73. PubMed ID: 15753637
[TBL] [Abstract][Full Text] [Related]
7. p16(INK4a) Promoter hypermethylation of non-tumorous tissue adjacent to gastric cancer is correlated with glandular atrophy and chronic inflammation.
Jang TJ; Kim DI; Shin YM; Chang HK; Yang CH
Int J Cancer; 2001 Sep; 93(5):629-34. PubMed ID: 11477571
[TBL] [Abstract][Full Text] [Related]
8. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
9. p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma.
Matsuda Y; Ichida T; Matsuzawa J; Sugimura K; Asakura H
Gastroenterology; 1999 Feb; 116(2):394-400. PubMed ID: 9922321
[TBL] [Abstract][Full Text] [Related]
10. p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach.
Lee WA; Woo DK; Kim YI; Kim WH
Pathol Res Pract; 1999; 195(11):747-52. PubMed ID: 10605694
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
12. Loss of expression of tumor suppressor p16(INK4) protein in human primary gastric cancer is related to the grade of differentiation.
Rocco A; Schandl L; Nardone G; Tulassay Z; Staibano S; Malfertheiner P; Ebert MP
Dig Dis; 2002; 20(1):102-5. PubMed ID: 12145426
[TBL] [Abstract][Full Text] [Related]
13. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.
Mattioli E; Vogiatzi P; Sun A; Abbadessa G; Angeloni G; D'Ugo D; Trani D; Gaughan JP; Vecchio FM; Cevenini G; Persiani R; Giordano A; Claudio PP
J Cell Physiol; 2007 Jan; 210(1):183-91. PubMed ID: 16998811
[TBL] [Abstract][Full Text] [Related]
15. [Methylation and expression of gene p16INK4a and RB in breast carcinoma].
Zhao YF; Shen SP; Jiang JY; Geng H; Guo JG; Xie LP
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):377-81. PubMed ID: 21055153
[TBL] [Abstract][Full Text] [Related]
16. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
[TBL] [Abstract][Full Text] [Related]
17. Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significance.
He XS; Rong YH; Su Q; Luo Q; He DM; Li YL; Chen Y
World J Gastroenterol; 2005 Apr; 11(15):2218-23. PubMed ID: 15818729
[TBL] [Abstract][Full Text] [Related]
18. Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues.
Kim BN; Yamamoto H; Ikeda K; Damdinsuren B; Sugita Y; Ngan CY; Fujie Y; Ogawa M; Hata T; Ikeda M; Ohue M; Sekimoto M; Monden T; Matsuura N; Monden M
Int J Oncol; 2005 May; 26(5):1217-26. PubMed ID: 15809712
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
20. Different roles for p16(INK) (4a) -Rb pathway and INK4a/ARF methylation between adenocarcinomas of gastric cardia and distal stomach.
Xue L; Ouyang Q; Li J; Meng X; Li Y; Xing L; Wang J; Yan X; Zhang X
J Gastroenterol Hepatol; 2014; 29(7):1418-26. PubMed ID: 25123601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
